User profiles for M. R. Loebinger
Michael LoebingerConsultant Respiratory Medicine, Royal Brompton Hospital Verified email at rbht.nhs.uk Cited by 10841 |
[HTML][HTML] British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
…, T Gorsuch, IF Laurenson, A Leitch, MR Loebinger… - Thorax, 2017 - thorax.bmj.com
Background Since the publication of the British Thoracic Society (BTS) Guideline on the ‘Management
of opportunistic mycobacterial infections’ in 2000, our understanding of the …
of opportunistic mycobacterial infections’ in 2000, our understanding of the …
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
Bronchiectasis refers to both a clinical disease and a radiological appearance that has multiple
causes and can be associated with a range of conditions. Disease heterogeneity and the …
causes and can be associated with a range of conditions. Disease heterogeneity and the …
Non-tuberculous mycobacterial pulmonary disease
…, J van Ingen, DE Griffith, MR Loebinger - European Respiratory …, 2019 - Eur Respiratory Soc
… Conflict of interest: MR Loebinger reports personal fees for advisory board work and lecturing
from Insmed, personal fees for advisory board work from Savara, outside the submitted …
from Insmed, personal fees for advisory board work from Savara, outside the submitted …
European Respiratory Society guidelines for the management of adult bronchiectasis
…, S Aliberti, SE Marshall, MR Loebinger… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …
exacerbations in many patients. There have been no previous international guidelines. The …
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer
Cancer is a leading cause of mortality throughout the world and new treatments are urgently
needed. Recent studies suggest that bone marrow–derived mesenchymal stem cells (MSC) …
needed. Recent studies suggest that bone marrow–derived mesenchymal stem cells (MSC) …
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
There is little literature about the mortality associated with bronchiectasis. The aim of the
present study was to investigate factors affecting mortality in patients with bronchiectasis. In total…
present study was to investigate factors affecting mortality in patients with bronchiectasis. In total…
[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults
…, M Tunney, D Whitters, R Wilson, MR Loebinger - Thorax, 2019 - thorax.bmj.com
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary ciliary …
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary ciliary …
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
…, P Flume, PC Goeminne, MR Loebinger… - European …, 2017 - Eur Respiratory Soc
There is a need for a clear definition of exacerbations used in clinical trials in patients with
bronchiectasis. An expert conference was convened to develop a consensus definition of an …
bronchiectasis. An expert conference was convened to develop a consensus definition of an …
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles
MR Loebinger, PG Kyrtatos, M Turmaine, AN Price… - Cancer research, 2009 - AACR
… -loaded MSCs 1 and 24 h after MSC injection was further confirmed and quantified by
comparing SNR between the lung parenchyma and the deltoid muscle in three consecutive MR …
comparing SNR between the lung parenchyma and the deltoid muscle in three consecutive MR …
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open …
…, TK Marras, PA Flume, MR Loebinger… - American journal of …, 2018 - atsjournals.org
Rationale: Improved therapeutic options are needed for patients with treatment-refractory
nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex (MAC). …
nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex (MAC). …